|
|
||||||||
From the Centre for Eye Research Australia, University of Melbourne, East Melbourne, Victoria.
PURPOSE. Recent studies in U.S. populations have indicated that the Y402H variant of the complement factor H (CFH) gene contains a major risk susceptibility allele for age-related macular degeneration (AMD). This study was conducted to ascertain whether this is also true in a non-U.S. population and also whether the at-risk allele is associated with the clinical phenotype of disease and the age at diagnosis.
METHODS. Two hundred thirty-six unrelated individuals with AMD and 144 unrelated but ethnically matched control subjects were recruited and examined. All subjects completed a standard questionnaire, were given a fundus examination, and provided a blood sample for DNA extraction. Alleles of Y402H in the CFH gene were determined by use of a MALDI-TOFbased approach followed by statistical analysis.
RESULTS. Individuals with AMD who had at least one copy of the C allele of Y402H had an increased risk of disease (odds ratio [OR] 2.98; 95% confidence interval [CI] 1.814.93) compared with cases with the T allele. On subgroup analysis, this risk was found to be most significant in individuals with neovascular disease (OR 4.34; 95% CI 1.94, 9.71). In addition, individuals with neovascular disease who were homozygous CC presented with a significant 7.0-year earlier age at diagnosis relative to those individuals who were homozygous TT. The population-attributable risk for the C allele ranged between 47% to 69%, depending on the AMD disease subtype.
CONCLUSIONS. The C allele of Y402H represents a significant risk factor in individuals with AMD, and this effect is most pronounced in individuals with neovascular disease.
This article has been cited by other articles:
![]() |
H. C. Bravo, K. E. Lee, B. E. K. Klein, R. Klein, S. K. Iyengar, and G. Wahba Examining the relative influence of familial, genetic, and environmental covariate information in flexible risk models PNAS, May 19, 2009; 106(20): 8128 - 8133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Liu, D Colville, Y Y Wang, P N Baird, R H Guymer, and J Savige The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms Br. J. Ophthalmol., March 1, 2009; 93(3): 379 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Richardson, F. M. A. Islam, R. H. Guymer, and P. N. Baird Analysis of Rare Variants in the Complement Component 2 (C2) and Factor B (BF) Genes Refine Association for Age-Related Macular Degeneration (AMD) Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 540 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Baird, L. D. Robman, A. J. Richardson, P. N. Dimitrov, G. Tikellis, C. A. McCarty, and R. H. Guymer Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection Hum. Mol. Genet., May 1, 2008; 17(9): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Droz, I Mantel, A Ambresin, M Faouzi, D F Schorderet, and F L Munier Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism Br. J. Ophthalmol., April 1, 2008; 92(4): 513 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S V Goverdhan, S Ennis, S R Hannan, K C Madhusudhana, A J Cree, A J Luff, and A J Lotery Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration Br. J. Ophthalmol., April 1, 2008; 92(4): 537 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Swaroop, K. E. Branham, W. Chen, and G. Abecasis Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits Hum. Mol. Genet., October 15, 2007; 16(R2): R174 - R182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Pulido, J. P. McConnell, L. M. Peterson, W. E. Highsmith, R. J. Lennon, S. C. Bryant, P. B. Berger, and V. Somers Relationship Between Age-Related Macular Degeneration-Associated Variants of Complement Factor H and LOC387715 With Coronary Artery Disease Mayo Clin. Proc., March 1, 2007; 82(3): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |